Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex

Journal of Clinical Microbiology

Volumn 39, Issue 3, 2001, Pages 1073-1078

  Henry, D A ^a   Mahenthiralingam, E ^a   Vandamme, P ^a   Coenye, T ^a   Speert, D P ^a  

^a British Columbia Research Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; BACTERIUM IDENTIFICATION; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; GENE CLUSTER; GENETIC ANALYSIS; GENOME; GENOTYPE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RALSTONIA;

BACTERIAL TYPING TECHNIQUES; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; DNA, RIBOSOMAL; GENES, RRNA; HUMANS; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REC A RECOMBINASES; RNA, RIBOSOMAL, 16S; RNA, RIBOSOMAL, 23S;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA GLADIOLI; BURKHOLDERIA MULTIVORANS; BURKHOLDERIA STABILIS; NEGIBACTERIA; PANDORAEA; RALSTONIA; RALSTONIA PICKETTII;

EID: 0035098325     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.3.1073-1078.2001     Document Type: Article

References (39)

1. Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients
2. Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR
3. Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients
4. Distribution of genes encoding putative transmissibility factors among epidemic and non-epidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom
5. Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting
6. Description of Pandoraea gen. nov. with Pandoraea pulmonicola sp. nov., Pandoraea apista sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov.
7. Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples
8. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients
9. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex comprising biocontrol and cystic fibrosis-related isolates
10. Characterization of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia
11. 2-fixing isolates from rice in Vietnam
12. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium
13. Strains of Pseudomonas putrefaciens from clinical material
14. The taxonomic significance of fermentative versus oxidative metabolism of carbohydrates by various gram-negative bacteria
15. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
16. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis
17. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients
18. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis
19. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: Analysis by random amplified polymorphic DNA fingerprinting
20. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis
21. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex
22. DNA-based diagnostic approaches for the identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, Burkholderia cepacia genomovars I and III
23. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers - An analysis of 1,051 recent sputum isolates
24. Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients
25. Analysis of electrophoretic whole-organism protein fingerprinting
26. Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients
27. Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers
28. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates
29. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture
30. Polyphasic taxonomic study of the emended genus Arcobacter with Arcobacter butzleri comb. nov. and Arcobacter skirrowii sp. nov., an aerotolerant bacterium isolated from veterinary specimens
31. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
32. Assignment of Centers for Disease Control group IVc-2 to the genus Ralstonia as Ralstonia paucula sp. nov.
33. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV)
34. Identification of Burkholderia spp. in the clinical microbiology laboratory: Comparison of conventional and molecular methods
35. Species-specific PCR as a tool for the identification of Burkholderia gladioli
36. Identification of members of the Burkholderia cepacia complex by species-specific PCR
37. Outcome of Burkholderia (Pseudomonas) cepacia colonization in children with cystic fibrosis following a hospital cut-break
38. Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis